Literature DB >> 26984696

Absence of a Periampullary Mass on Cross-sectional Imaging Delays Diagnosis and Time to Pancreatoduodenectomy But Does Not Impair Outcome.

Hideo Takahashi1, Maitham A Moslim2, Naftali Presser2, Colin O'Rourke3, Jane Wey2, Sricharan Chalikonda2, Matthew R Walsh2, Gareth Morris-Stiff2.   

Abstract

BACKGROUND: The aim of this study was to assess whether the lack of a radiological mass in patients with periampullary malignancies led to protracted diagnosis, delayed resection, and an inferior outcome.
METHODS: The departmental database was interrogated to identify all patients undergoing pancreatoduodenectomy during the period 2000-2014. The absence of a mass on cross-sectional and endoscopic ultrasound was noted. The interval between imaging and surgery was evaluated and related to the absence of a mass. The relationship between mass/no mass and the pathological profile was also assessed.
RESULTS: Among 490 patients who underwent pancreatoduodenectomy for periampullary malignancies, masses were detected in 299 patients. Patients with undetected mass on either endoscopic ultrasonography (EUS) or computed tomography (CT)/magnetic resonance imaging (MRI) had a longer median interval from initial imaging to resection than detected mass with no difference in survival (66 vs. 41 days, p = 0.001). The absence of a mass was more common in cholangiocarcinomas (p < 0.001). The absence of a mass on imaging was associated with smaller size on final histopathology (2.4 vs. 2.8 cm; p < 0.001).
CONCLUSIONS: The absence of a mass with all modalities in patients with a periampullary malignancy leads to a delayed diagnosis without a significant effect on survival.

Entities:  

Keywords:  Endoscopic ultrasound; Pancreatic neoplasms; Pancreatoduodenectomy

Mesh:

Year:  2016        PMID: 26984696     DOI: 10.1007/s11605-016-3127-x

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  22 in total

1.  Surgical treatment for ampullary carcinoma.

Authors:  R C Smith
Journal:  Aust N Z J Surg       Date:  1999-03

2.  Role of endoscopic ultrasonography in patients suspected of pancreatic cancer with negative helical MDCT scan.

Authors:  Eva B Deerenberg; Jan-Werner Poley; John J Hermans; Sjam Ganesh; Erwin van der Harst; Casper H J van Eijck
Journal:  Dig Surg       Date:  2011-12-20       Impact factor: 2.588

3.  Value of intraoperative neck margin analysis during Whipple for pancreatic adenocarcinoma: a multicenter analysis of 1399 patients.

Authors:  David A Kooby; Neha L Lad; Malcolm H Squires; Shishir K Maithel; Juan M Sarmiento; Charles A Staley; N Volkan Adsay; Bassel F El-Rayes; Sharon M Weber; Emily R Winslow; Clifford S Cho; Kathryn A Zavala; David J Bentrem; Mark Knab; Syed A Ahmad; Daniel E Abbott; Jeffrey M Sutton; Hong Jin Kim; Jen Jen Yeh; Rachel Aufforth; Charles R Scoggins; Robert C Martin; Alexander A Parikh; Jamie Robinson; Yassar M Hashim; Ryan C Fields; William G Hawkins; Nipun B Merchant
Journal:  Ann Surg       Date:  2014-09       Impact factor: 12.969

4.  PET and PET/CT for pancreatic malignancies.

Authors:  Dominique Delbeke; William H Martin
Journal:  Surg Oncol Clin N Am       Date:  2010-04       Impact factor: 3.495

5.  Benign histology after pancreaticoduodenectomy for suspected malignancy. Lessons to be learned--a single centre experience.

Authors:  Jakub Wojcicki; Yoy Zen; Praveen Peddu; Rajeev Jain; Ameet G Patel; Simon Atkinson; Parthi Srinivasan; Mohammed Rela; Nigel Heaton; Andreas Prachalias
Journal:  Pol Przegl Chir       Date:  2015-01

6.  Retrospective analysis of dual-phase MDCT and follow-up EUS/EUS-FNA in the diagnosis of pancreatic cancer.

Authors:  Eric P Tamm; Evelyne M Loyer; Silvana C Faria; Douglas B Evans; Robert A Wolff; Chusilp Charnsangavej
Journal:  Abdom Imaging       Date:  2007 Sep-Oct

7.  Patients with obstructive jaundice and biliary stricture ± mass lesion on imaging: prevalence of malignancy and potential role of EUS-FNA.

Authors:  Pavan Tummala; Satish Munigala; Mohamad A Eloubeidi; Banke Agarwal
Journal:  J Clin Gastroenterol       Date:  2013-07       Impact factor: 3.062

Review 8.  Imaging preoperatively for pancreatic adenocarcinoma.

Authors:  Jason Alan Pietryga; Desiree E Morgan
Journal:  J Gastrointest Oncol       Date:  2015-08

Review 9.  Imaging diagnosis of pancreatic cancer: a state-of-the-art review.

Authors:  Eun Sun Lee; Jeong Min Lee
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

10.  When to perform a pancreatoduodenectomy in the absence of positive histology? A consensus statement by the International Study Group of Pancreatic Surgery.

Authors:  Horacio J Asbun; Kevin Conlon; Laureano Fernandez-Cruz; Helmut Friess; Shailesh V Shrikhande; Mustapha Adham; Claudio Bassi; Maximilian Bockhorn; Markus Büchler; Richard M Charnley; Christos Dervenis; Abe Fingerhutt; Dirk J Gouma; Werner Hartwig; Clem Imrie; Jakob R Izbicki; Keith D Lillemoe; Miroslav Milicevic; Marco Montorsi; John P Neoptolemos; Aken A Sandberg; Michael Sarr; Charles Vollmer; Charles J Yeo; L William Traverso
Journal:  Surgery       Date:  2014-01-02       Impact factor: 3.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.